Participants with persistently raised CRP, peaking at age 9 years, had increased risk for psychotic disorder, severe depression<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, Aug. 23, 2024 (HealthDay News) — Low-grade systemic inflammation across childhood and adolescence is associated with the subsequent onset of mental health disorders, according to a study published online Aug. 21 in JAMA Psychiatry<\/em>.<\/p>\n Edward R. Palmer, M.B.B.S., from the University of Birmingham in the United Kingdom, and colleagues examined trajectories of inflammation, as measured by C-reactive protein (CRP), in children and adolescents using data from the U.K.-based Avon Longitudinal Study of Parents and Children; inflammation was assessed at ages 9, 15, and 17 years. Data were included for 6,556 participants; outcomes were assessed at age 24 years.<\/p>\n The researchers identified three classes of inflammation: persistently low CRP levels (6,109 individuals) and persistently elevated CRP levels peaking at 9 years and 17 years (early peak, 197 individuals; late peak, 250 individuals). Compared with participants with persistently low CRP, participants in the early-peak group had an increased risk for psychotic disorder (odds ratio, 4.60), a higher risk for severe depression (odds ratio, 4.37), and higher Homeostasis Model Assessment scores (\u00ce\u00b2 = 0.05). No associations with outcomes were seen for the late-peak group.<\/p>\n “This study adds new information about the chronicity and timing of inflammation predating illness and provides insight into the co-occurrence of related cardiometabolic disorders,” the authors write.<\/p>\n One author disclosed ties to the pharmaceutical and health care industries.<\/p>\n